Relay Therapeutics Inc
NASDAQ:RLAY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Relay Therapeutics Inc
NASDAQ:RLAY
|
US |
|
H
|
Home Depot Inc
XETRA:HDI
|
US |
|
Playstudios Inc
NASDAQ:MYPS
|
US |
|
Note AB (publ)
STO:NOTE
|
SE |
|
T
|
Taiwan Semiconductor Manufacturing Co Ltd
F:TSFA
|
TW |
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
US |
|
A
|
Autodesk Inc
F:AUD
|
US |
|
Summit Materials Inc
NYSE:SUM
|
US |
|
Boise Cascade Co
NYSE:BCC
|
US |
|
L
|
Lgi Ltd
ASX:LGI
|
AU |
|
Portillos Inc
NASDAQ:PTLO
|
US |
|
C
|
Cal-Comp Electronics Thailand PCL
SET:CCET
|
TH |
|
Post Holdings Inc
NYSE:POST
|
US |
Wall St Price Targets
RLAY Price Targets Summary
Relay Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
RLAY is 21.42 USD with a low forecast of 18.18 USD and a high forecast of 26.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RLAY's stock price target?
Price Target
21.42
USD
According to Wall Street analysts, the average 1-year price target for
RLAY is 21.42 USD with a low forecast of 18.18 USD and a high forecast of 26.25 USD.
What is the Revenue forecast for Relay Therapeutics Inc?
Projected CAGR
74%
The compound annual growth rate for Revenue over the next 8 years is 74%.